Other studies of hepatocellular carcinoma (HCC) patients have demonstrated a positive correlation between lower plasma concentrations of IFN-γ, advanced tumor stage, and higher rates of HCC recurrence [129]. This evidence concerns the gene IFNG and hepatocellular carcinoma.